PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, LY4257496, that delivers radiation directly to cancer cells with a specific protein (GRPR). It is for adults with advanced solid tumors like breast, prostate, or colorectal cancer that have not responded to other treatments. The goal is to see if the …
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Boosting radiation for prostate cancer: a safer cure?
Disease control Recruiting nowThis study tests whether giving a higher dose of radiation directly to the prostate (via HDR brachytherapy) can better control early-stage prostate cancer without causing too many side effects. About 36 men with low- or favorable intermediate-risk prostate cancer will receive one…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New AI tool could spot hidden prostate cancer on MRI scans
Diagnosis Recruiting nowThis study tests a new software tool that automatically analyzes MRI images of the prostate to find cancer areas that doctors might miss. About 180 people with known or suspected prostate cancer will get an MRI and then a targeted biopsy. Researchers will compare the software's a…
Matched conditions: PROSTATE NEOPLASM
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New hope for men battling hot flashes from prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy (androgen deprivation therapy). About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Mayo clinic tests smarter MRI to spot prostate cancer without dye
Knowledge-focused Recruiting nowThis study at Mayo Clinic is testing whether new computer algorithms can make MRI images of the prostate clearer, both with and without contrast dye. Researchers will compare standard images to those created using the new method. The goal is to improve how doctors see blood flow …
Matched conditions: PROSTATE NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
8,000-Patient study aims to sharpen cancer radiation with Real-Time MRI
Knowledge-focused Recruiting nowThis study is a large registry that will follow about 8,000 cancer patients who receive radiation therapy using a special machine called an MR-Linac, which combines an MRI scanner with a radiation beam. The goal is to learn how well this technology works for different cancers, in…
Matched conditions: PROSTATE NEOPLASM
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC